MichaelBoyiadzisMD
Oncology • Pittsburgh, PAAssistant Professor, Medicine, University of Pittsburgh School of Medicine
Are you Dr. Boyiadzis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Meyran Ave
Suite 318
Pittsburgh, PA 15213Phone+1 412-586-9874Fax+1 412-647-4486
Summary
- Dr. Michael Boyiadzis, MD is an oncologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and Maryland. He is affiliated with UPMC Presbyterian Shadyside, UPMC Magee-Womens Hospital, and Shadyside Campus.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2001 - 2005
St Agnes HealthCareResidency, Internal Medicine, 1998 - 2001
University of Debrecen Medical and Health Science CenterClass of 1995
Certifications & Licensure
PA State Medical License 2004 - 2024
MD State Medical License 2001 - 2006
Clinical Trials
- Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia Start of enrollment: 2008 Sep 01
- QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia Start of enrollment: 2014 May 12
- Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Start of enrollment: 2012 Dec 13
- Join now to see all
Publications & Presentations
PubMed
- 120 citationsPhase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.Michael Boyiadzis, Mounzer Agha, Robert L. Redner, Alison R. Sehgal, Annie Im
Cytotherapy. 2017-10-01 - 152 citationsThe emerging roles of tumor-derived exosomes in hematological malignanciesMichael Boyiadzis, Theresa L. Whiteside
Leukemia. 2017-03-21 - 152 citationsCirculating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemiaChang-Sook Hong, Priyanka Sharma, Saigopalakrishna S. Yerneni, Patricia E. Simms, Edwin K. Jackson
Scientific Reports. 2017-10-31
Press Mentions
- DPP4+ Exosomes in AML Patients’ Plasma Suppress Proliferation of Hematopoietic Progenitor CellsNovember 2nd, 2020
